34 results on '"Dwoskin, Linda"'
Search Results
2. Methamphetamine effects in zebrafish (Danio rerio) depend on behavioral endpoint, dose and test session duration
3. Short-term CaMKII inhibition with tatCN19o does not erase pre-formed memory in mice and is neuroprotective in pigs
4. Toward isolating reward changes in diet-induced obesity: A demand analysis
5. Competency, Programming, and Emerging Innovation in Graduate Education within Schools of Pharmacy: The Report of the 2016-2017 Research and Graduate Affairs Committee
6. Obesity: Current and potential pharmacotherapeutics and targets
7. Necessity for research directed at stimulant type and treatment-onset age to access the impact of medication on drug abuse vulnerability in teenagers with ADHD
8. Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder
9. Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in rats
10. Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [3H]dopamine and [3H]norepinephrine release
11. Adolescence methylphenidate treatment in a rodent model of attention deficit/hyperactivity disorder: Dopamine transporter function and cellular distribution in adulthood
12. Potential therapeutic uses of mecamylamine and its stereoisomers
13. Pharmacology biochemistry and behavior: Personal perspectives from 50 years ago
14. Repeated nicotine administration robustly increases bPiDDB inhibitory potency at α6β2-containing nicotinic receptors mediating nicotine-evoked dopamine release
15. Mecamylamine, dihydro-β-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine
16. The novel nicotinic receptor antagonist, N, N′-dodecane-1,12-diyl- bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [ 3H]norepinephrine overflow from rat hippocampal slices
17. Nicotinic receptor-based therapeutics and candidates for smoking cessation
18. 55 - Methamphetamine
19. Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD)
20. Identification and synthesis of novel alkaloids from the root system of Nicotiana tabacum: Affinity for neuronal nicotinic acetylcholine receptors
21. A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers
22. Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats
23. Mitochondrial toxin inhibition of [ [formula omitted]]dopamine uptake into rat striatal synaptosomes
24. Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [ 3H]dopamine overflow from rat nucleus accumbens slices
25. Contributors
26. Chapter Thirteen - Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
27. Chapter Two - The Vesicular Monoamine Transporter-2: An Important Pharmacological Target for the Discovery of Novel Therapeutics to Treat Methamphetamine Abuse
28. Preface
29. A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse
30. Evidence for antiserotonergic properties of yohimbine
31. Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine autoreceptors to pergolide
32. Inhibition of [ 3H]dopamine uptake into rat striatal slices by quaternary n-methylated nicotine metabolites
33. Irreversible inhibition of rat striatal dopamine uptake induced by in vitro exposure to DSP4
34. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.